Earnings Feed
Start Free
Home/Filings/4/0000950170-25-002864
4//SEC Filing

Patel Samir Rashmikant 4

Accession 0000950170-25-002864

CIK 0001541157other
View on SEC.govCompany Profile

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:30 PM ET

Size

8.1 KB

Accession

0000950170-25-002864

Insider Transaction Report

Form 4
Period: 2025-01-03
Akari Therapeutics PlcAKTX
Patel Samir Rashmikant
Director
Transactions
  • Award

    Ordinary Shares, par value $0.0001 per share

    2025-01-03$0.00/sh+208,000$125→ 5,249,511,500 total(indirect: By LLC)
  • Award

    Stock Option (Right to Buy)

    2025-01-03+152,672,000→ 152,672,000 total
    Exercise: $0.00From: 2025-01-03Exp: 2035-01-03→ Ordinary Shares, par value $0.0001 per share (152,672,000 underlying)
Holdings

  • Ordinary Shares, par value $0.0001 per share

    91,396,000
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
  • [F2]On January 3, 2025, the Reporting Person acquired 208,000 Ordinary Shares at a purchase price of $0.0006 per Ordinary Share.
  • [F3]The stock options have an exercise price of $0.000655 per Ordinary Share.

Documents

1 file

Issuer

Akari Therapeutics Plc

CIK 0001541157

→
Entity typeother

Related Parties

1
  • filerCIK 0001702447

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:30 PM ET
Size
8.1 KB
View on SEC.gov